Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice

Genomic Ascertainment Cohort

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Nanophthalmos is a rare, potentially devastating eye condition characterized by small eyes with relatively normal anatomy, a high hyperopic refractive error, and frequent association with angle closure glaucoma and vision loss. The condition constitutes the extreme of hyperopia or farsightedness, a common refractive error that is associated with strabismus and amblyopia in children. NNO1 was the first mapped nanophthalmos locus. We used combined pooled exome sequencing and strong linkage data in the large family used to map this locus to identify a canonical splice site alteration upstream of the last exon of the gene encoding myelin regulatory factor (MYRF c.3376-1G>A), a membrane bound transcription factor that undergoes autoproteolytic cleavage for nuclear localization. This variant produced a stable RNA transcript, leading to a frameshift mutation p.Gly1126Valfs*31 in the C-terminus of the protein. In addition, we identified an early truncating MYRF frameshift mutation, c.769dupC (p.S264QfsX74), in a patient with extreme axial hyperopia and syndromic features. Myrf conditional knockout mice (CKO) developed depigmentation of the retinal pigment epithelium (RPE) and retinal degeneration supporting a role of this gene in retinal and RPE development. Furthermore, we demonstrated the reduced expression of Tmem98, another known nanophthalmos gene, in Myrf CKO mice, and the physical interaction of MYRF with TMEM98. Our study establishes MYRF as a nanophthalmos gene and uncovers a new pathway for eye growth and development.

Original languageEnglish (US)
Pages (from-to)e1008130
JournalPLoS genetics
Volume15
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Retinal Degeneration
myelin sheath
Myelin Sheath
Hyperopia
gene
mice
frameshift mutation
Frameshift Mutation
Refractive Errors
Retinal Pigment Epithelium
eyes
pigment
mutation
Knockout Mice
Genes
epithelium
genes
pigments
Exome
Angle Closure Glaucoma

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Cite this

Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. / Genomic Ascertainment Cohort.

In: PLoS genetics, Vol. 15, No. 5, 01.05.2019, p. e1008130.

Research output: Contribution to journalArticle

@article{47256072c7a44f01b3a1867fdb81eb08,
title = "Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice",
abstract = "Nanophthalmos is a rare, potentially devastating eye condition characterized by small eyes with relatively normal anatomy, a high hyperopic refractive error, and frequent association with angle closure glaucoma and vision loss. The condition constitutes the extreme of hyperopia or farsightedness, a common refractive error that is associated with strabismus and amblyopia in children. NNO1 was the first mapped nanophthalmos locus. We used combined pooled exome sequencing and strong linkage data in the large family used to map this locus to identify a canonical splice site alteration upstream of the last exon of the gene encoding myelin regulatory factor (MYRF c.3376-1G>A), a membrane bound transcription factor that undergoes autoproteolytic cleavage for nuclear localization. This variant produced a stable RNA transcript, leading to a frameshift mutation p.Gly1126Valfs*31 in the C-terminus of the protein. In addition, we identified an early truncating MYRF frameshift mutation, c.769dupC (p.S264QfsX74), in a patient with extreme axial hyperopia and syndromic features. Myrf conditional knockout mice (CKO) developed depigmentation of the retinal pigment epithelium (RPE) and retinal degeneration supporting a role of this gene in retinal and RPE development. Furthermore, we demonstrated the reduced expression of Tmem98, another known nanophthalmos gene, in Myrf CKO mice, and the physical interaction of MYRF with TMEM98. Our study establishes MYRF as a nanophthalmos gene and uncovers a new pathway for eye growth and development.",
author = "{Genomic Ascertainment Cohort} and Garnai, {Sarah J.} and Brinkmeier, {Michelle L.} and Ben Emery and Aleman, {Tomas S.} and Pyle, {Louise C.} and Biliana Veleva-Rotse and Sisk, {Robert A.} and Rozsa, {Frank W.} and Ozel, {Ayse Bilge} and Li, {Jun Z.} and Moroi, {Sayoko E.} and Archer, {Steven M.} and Lin, {Cheng Mao} and Sarah Sheskey and Laurel Wiinikka-Buesser and James Eadie and Urquhart, {Jill E.} and Black, {Graeme C.M.} and Othman, {Mohammad I.} and Michael Boehnke and Sullivan, {Scot A.} and Skuta, {Gregory L.} and Pawar, {Hemant S.} and Katz, {Alexander E.} and Huryn, {Laryssa A.} and Hufnagel, {Robert B.} and Camper, {Sally A.} and Richards, {Julia E.} and Lev Prasov",
year = "2019",
month = "5",
day = "1",
doi = "10.1371/journal.pgen.1008130",
language = "English (US)",
volume = "15",
pages = "e1008130",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice

AU - Genomic Ascertainment Cohort

AU - Garnai, Sarah J.

AU - Brinkmeier, Michelle L.

AU - Emery, Ben

AU - Aleman, Tomas S.

AU - Pyle, Louise C.

AU - Veleva-Rotse, Biliana

AU - Sisk, Robert A.

AU - Rozsa, Frank W.

AU - Ozel, Ayse Bilge

AU - Li, Jun Z.

AU - Moroi, Sayoko E.

AU - Archer, Steven M.

AU - Lin, Cheng Mao

AU - Sheskey, Sarah

AU - Wiinikka-Buesser, Laurel

AU - Eadie, James

AU - Urquhart, Jill E.

AU - Black, Graeme C.M.

AU - Othman, Mohammad I.

AU - Boehnke, Michael

AU - Sullivan, Scot A.

AU - Skuta, Gregory L.

AU - Pawar, Hemant S.

AU - Katz, Alexander E.

AU - Huryn, Laryssa A.

AU - Hufnagel, Robert B.

AU - Camper, Sally A.

AU - Richards, Julia E.

AU - Prasov, Lev

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Nanophthalmos is a rare, potentially devastating eye condition characterized by small eyes with relatively normal anatomy, a high hyperopic refractive error, and frequent association with angle closure glaucoma and vision loss. The condition constitutes the extreme of hyperopia or farsightedness, a common refractive error that is associated with strabismus and amblyopia in children. NNO1 was the first mapped nanophthalmos locus. We used combined pooled exome sequencing and strong linkage data in the large family used to map this locus to identify a canonical splice site alteration upstream of the last exon of the gene encoding myelin regulatory factor (MYRF c.3376-1G>A), a membrane bound transcription factor that undergoes autoproteolytic cleavage for nuclear localization. This variant produced a stable RNA transcript, leading to a frameshift mutation p.Gly1126Valfs*31 in the C-terminus of the protein. In addition, we identified an early truncating MYRF frameshift mutation, c.769dupC (p.S264QfsX74), in a patient with extreme axial hyperopia and syndromic features. Myrf conditional knockout mice (CKO) developed depigmentation of the retinal pigment epithelium (RPE) and retinal degeneration supporting a role of this gene in retinal and RPE development. Furthermore, we demonstrated the reduced expression of Tmem98, another known nanophthalmos gene, in Myrf CKO mice, and the physical interaction of MYRF with TMEM98. Our study establishes MYRF as a nanophthalmos gene and uncovers a new pathway for eye growth and development.

AB - Nanophthalmos is a rare, potentially devastating eye condition characterized by small eyes with relatively normal anatomy, a high hyperopic refractive error, and frequent association with angle closure glaucoma and vision loss. The condition constitutes the extreme of hyperopia or farsightedness, a common refractive error that is associated with strabismus and amblyopia in children. NNO1 was the first mapped nanophthalmos locus. We used combined pooled exome sequencing and strong linkage data in the large family used to map this locus to identify a canonical splice site alteration upstream of the last exon of the gene encoding myelin regulatory factor (MYRF c.3376-1G>A), a membrane bound transcription factor that undergoes autoproteolytic cleavage for nuclear localization. This variant produced a stable RNA transcript, leading to a frameshift mutation p.Gly1126Valfs*31 in the C-terminus of the protein. In addition, we identified an early truncating MYRF frameshift mutation, c.769dupC (p.S264QfsX74), in a patient with extreme axial hyperopia and syndromic features. Myrf conditional knockout mice (CKO) developed depigmentation of the retinal pigment epithelium (RPE) and retinal degeneration supporting a role of this gene in retinal and RPE development. Furthermore, we demonstrated the reduced expression of Tmem98, another known nanophthalmos gene, in Myrf CKO mice, and the physical interaction of MYRF with TMEM98. Our study establishes MYRF as a nanophthalmos gene and uncovers a new pathway for eye growth and development.

UR - http://www.scopus.com/inward/record.url?scp=85066456116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066456116&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1008130

DO - 10.1371/journal.pgen.1008130

M3 - Article

C2 - 31048900

AN - SCOPUS:85066456116

VL - 15

SP - e1008130

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 5

ER -